Alternative Treatment for Iatrogenic Dermatoporosis
Main Article Content
Abstract
A healthy 60-year-old female patient, with a history of Quervain's Syndrome, presented with corticosteroid-induced dermatoporosis after receiving intra-articular corticosteroid injections. She experienced skin fragility and aesthetic discomfort due to dermal atrophy and a violaceous macule at the injection site. Treatment with calcium hydroxyapatite (CaHA) biostimulator was initiated, resulting in significant improvements in skin quality and pigmentation. Following two sessions, the patient reported enhanced self-esteem and satisfaction with the treatment outcomes. This case underscores the potential of CaHA as an effective therapeutic option for managing early stages of dermatoporosis.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Kaya G, Saurat JH. Dermatoporosis: A Chronic Cutaneous Insufficiency/Fragility Syndrome. Dermatology. 2007;215(4):284–94.
Hafsi W, Masood S, Badri T. Actinic Purpura. 2024.
Oikarinen A, Autio P. New aspects of the mechanism of corticosteroid–induced dermal atrophy. Clin Exp Dermatol. 1991 Nov 27;16(6):416–9.
Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol. 2014;59(5):456.
Barnes L, Tran C, Sorg O, Hotz R, Grand D, Carraux P, et al. Synergistic Effect of Hyaluronate Fragments in Retinaldehy-de-Induced Skin Hyperplasia Which Is a Cd44-Dependent Phenomenon. PLoS One. 2010 Dec 16;5(12):e14372.
Dahl PR, Zalla MJ, Winkelmann RK. Localized involutional lipoatrophy: A clinicopathologic study of 16 patients. J Am Acad Dermatol. 1996 Oct;35(4):523–8.
Ahmed I. Post-Injection Involutional Lipoatrophy. Am J Dermatopathol. 2006 Aug;28(4):334–7.
Pace CS, Blanchet NP, Isaacs JE. Soft Tissue Atrophy Related to Corticosteroid Injection: Review of the Literature and Im-plications for Hand Surgeons. J Hand Surg Am. 2018 Jun;43(6):558–63.
Brinks A, Koes BW, Volkers AC, Verhaar JA, Bierma-Zeinstra SM. Adverse effects of extra-articular corticosteroid injections: a systematic review. BMC Musculoskelet Disord. 2010 Dec 13;11(1):206.
Imagawa K, Ohkuma S. A case of fat injection for treating subcutaneous atrophy caused by local administration of corticos-teroid. Tokai J Exp Clin Med. 2010 Jul 20;35(2):66–9.
Aguilera SB, McCarthy A, Khalifian S, Lorenc ZP, Goldie K, Chernoff WG. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review. Aesthet Surg J. 2023 Sep 14;43(10):1063–90.
Tzikas TL. A 52-Month Summary of Results Using Calcium Hydroxylapatite for Facial Soft Tissue Augmentation. Derma-tologic Surgery. 2008 Jun;34(s1):S9–15.
de Souza GP, Serra MS. Treatment of actinic purpura with calcium hydroxyapatite. Surgical and Cosmetic Dermatology. 2018;10(4):353–6.